Business
Repayment of Loan
Repayment of Loan.
About this update from Proteome Sciences Plc
[{"type":"text","content":"\n\n1 June 2023\n \n \nProteome Sciences plc\n(\"Proteome Sciences\" or the \"Company\")\n \nRepayment of Loan to Vulpes Investment Management Private Limited\n \nThe Directors of Proteome are pleased to announce that the Company has today repaid in full the outstanding loan and associated interest (together totalling £824,424) to Vulpes Investment Management Private Limited originally announced on 2 July 2018 and amended on 30 March 2022.\n \n\n\n\n \nProteome Sciences plc\n\n\n\n\nDr. Mariola Soehngen, Chief Executive Officer\nDr. Ian Pike, Chief Scientific Officer\n\n\nTel: +44 (0)20 7043 2116\n\n\n \n\n\n\n\nRichard Dennis, Chief Commercial Officer\nAbdelghani Omari, Chief Financial Officer\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\nAllenby Capital Limited (Nominated Adviser & Broker) \n\n\n \n\n\n\n\nJohn Depasquale / Jeremy Porter (Corporate Finance)\nTony Quirke / Stefano Aquilino (Equity Sales & Corporate Broking)\n \n\n\nTel: +44 (0) 20 3328 5656\n\n\n \n\n\n\n\n \n\n\n\n \n \nAbout Proteome Sciences plc. (www.proteomics.com)\n \nProteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant® and TMT®MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator™ provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.\n \n \n\n","length":5129,"tagName":"div"}]